These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31337114)

  • 1. Systemic Dental Pulp Stem Cell Secretome Therapy in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Wang J; Zuzzio K; Walker CL
    Brain Sci; 2019 Jul; 9(7):. PubMed ID: 31337114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
    Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Secretome of Human Dental Pulp Stem Cells and Its Components GDF15 and HB-EGF Protect Amyotrophic Lateral Sclerosis Motoneurons against Death.
    Younes R; Issa Y; Jdaa N; Chouaib B; Brugioti V; Challuau D; Raoul C; Scamps F; Cuisinier F; Hilaire C
    Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice.
    Barbosa M; Santos M; de Sousa N; Duarte-Silva S; Vaz AR; Salgado AJ; Brites D
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in peripheral axons delays disease progression in SOD1
    Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
    J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
    Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
    Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epothilone D accelerates disease progression in the SOD1
    Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.
    Iyer AK; Jones KJ; Sanders VM; Walker CL
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
    Tremblay E; Martineau É; Robitaille R
    J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
    Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
    Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
    Yoo YE; Ko CP
    Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the Secretome of Dental Pulp Stem Cells Under Variable Microenvironmental Conditions.
    Bousnaki M; Bakopoulou A; Pich A; Papachristou E; Kritis A; Koidis P
    Stem Cell Rev Rep; 2022 Apr; 18(4):1372-1407. PubMed ID: 34553309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.